Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2.
Journal: Critical care explorations
Published: April 05, 2021
A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline.
Journal: Infectious diseases and therapy
Published: August 12, 2020
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.
Journal: Clinical and translational science
Published: July 02, 2020
Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program.
Journal: Open forum infectious diseases
Published: June 20, 2016
Showing 1-4 of 4
Last Updated: 09/26/2026